Scientific Conferences for The College on Problems of Drug Dependence (CPDD)
药物依赖问题学院科学会议(CPDD)
基本信息
- 批准号:10377420
- 负责人:
- 金额:$ 9.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
ABSTRACT
This is a request for a 5-year renewal of grant R13DA013192 to continue to support travel awards for
trainees and early career researchers to attend annual meetings of the College on Problems of Drug
Dependence (CPDD). CPDD is the oldest scientific society dedicated to substance use research. As
the only annual national or international meeting that brings together researchers studying all aspects
and approaches to the problems of substance use, CPDD’s conference provides a particularly
enriching experience for trainees and early career researchers in the field. The meeting attracts basic
and clinical researchers from throughout the United States and about 40 countries, at all career stages
from predoctoral students through senior investigators, as well as representatives from government and
industry. It includes scientists, physicians, nurses, clinical psychologists, administrators, policy makers,
journalists and others working on or interested in substance use research. Our meetings are a forum for
researchers from a broad range of disciplines (e.g., medicinal chemistry, molecular biology,
pharmacology, genetics, neuroimaging, psychology, sociology, addiction medicine, public health,
epidemiology) to share their recent findings, network and learn from one another in formal and informal
exchanges. We expect 1000-1300 attendees at each of our future meetings supported by this
competing renewal. In the next funding period, we propose to continue to support travel awards for
trainees and early career researchers to attend the CPDD annual meetings. Topics addressed at the
meeting change with emerging concerns and cutting-edge research in the field, and, each year,
sessions highly relevant to NIDA's major program areas (e.g., epidemiology, prevention, health
services, medications development, neuroscience, behavior, HIV/AIDS and health disparities) are
included. Presentations span the full range of drugs of abuse, including opioids, stimulants, sedatives,
cannabis, hallucinogens, nicotine and alcohol. The conference includes awards lectures and forums on
policy, animal and human research, industry/academia/government collaboration and media outreach,
as well as activities directed towards trainees, early career researchers, underrepresented minorities
and international scientists. We expect our annual meetings to accelerate innovation in substance use
research through the translational nature of our content and through the collaborations that are built
between attendees across the disciplines represented at the meeting. We also expect findings
presented at the meeting to reach a broader audience due to our media outreach activities and newly
developed virtual offerings, which can significantly improve prevention and treatment of substance use
disorders and inform policy as it relates to substance use.
抽象的
这是要求授予R13DA013192的5年续期的要求,以继续支持旅行奖
学员和早期职业研究人员参加学院的毒品问题年度会议
依赖性(CPDD)。 CPDD是致力于物质使用研究的最古老的科学学会。作为
唯一将研究各个方面的研究人员汇集在一起的年度国家或国际会议
以及解决药物使用问题的方法,CPDD的会议提供了一个特别的
为学员和该领域的早期职业研究人员提供丰富的经验。会议景点基本
以及来自美国和大约40个国家的临床研究人员,在所有职业阶段
从高级调查员到毒品的学生,以及政府的代表
行业。它包括科学家,医师,护士,临床心理学家,管理人员,政策制定者,
记者和其他从事药物使用研究或感兴趣的人。我们的会议是一个论坛
来自广泛学科的研究人员(例如药物化学,分子生物学,
药理学,遗传学,神经影像学,心理学,社会学,成瘾医学,公共卫生,公共卫生,
流行病学)分享他们最近的发现,网络并以正式和非正式的方式互相学习
交流。我们希望我们在此支持的每个未来会议上有1000-1300名与会者
竞争更新。在下一个资金期间,我们建议继续支持
学员和早期职业研究人员参加CPDD年度会议。主题在
在该领域以及每年的新兴问题和尖端研究中满足变化
会议与NIDA的主要计划领域高度相关(例如流行病学,预防,健康
服务,药物开发,神经科学,行为,艾滋病毒/艾滋病和健康分配)是
演讲涵盖了包括阿片类药物,兴奋剂,镇静剂,包括的全部滥用药物
大麻,致幻剂,尼古丁和酒精。会议包括奖励讲座和论坛
政策,动物和人类研究,工业/学术界/政府合作与媒体宣传,
以及针对学员,早期职业研究人员的活动,代表人数不足
和国际科学家。我们希望我们的年度会议能够加快使用物质的创新
通过我们内容的翻译性质以及建立的合作进行研究
在会议上代表的各个学科的参与者之间。我们也期待发现
由于我们的媒体外展活动和新的
开发的虚拟产品,可以显着改善预防和治疗物质使用
疾病并告知与物质使用有关的政策。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
William Walton Stoops其他文献
Acute inhibitory control training in cocaine users
- DOI:10.1016/j.drugalcdep.2016.08.02910.1016/j.drugalcdep.2016.08.029
- 发表时间:2017-02-012017-02-01
- 期刊:
- 影响因子:
- 作者:Joseph L. Alcorn;Erika Pike;Joshua A. Lile;William Walton Stoops;Craig R. RushJoseph L. Alcorn;Erika Pike;Joshua A. Lile;William Walton Stoops;Craig R. Rush
- 通讯作者:Craig R. RushCraig R. Rush
The influence of buspirone maintenance on the pharmacodynamic effects of methamphetamine
- DOI:10.1016/j.drugalcdep.2016.08.48110.1016/j.drugalcdep.2016.08.481
- 发表时间:2017-02-012017-02-01
- 期刊:
- 影响因子:
- 作者:Anna R. Reynolds;William Walton Stoops;Joshua A. Lile;Craig R. RushAnna R. Reynolds;William Walton Stoops;Joshua A. Lile;Craig R. Rush
- 通讯作者:Craig R. RushCraig R. Rush
共 2 条
- 1
William Walton Sto...的其他基金
Influence of 5-HT1b Activation on the Abuse Related Effects of Cocaine
5-HT1b 激活对可卡因滥用相关影响的影响
- 批准号:1045781110457811
- 财政年份:2021
- 资助金额:$ 9.5万$ 9.5万
- 项目类别:
Scientific Conferences for The College on Problems of Drug Dependence (CPDD)
药物依赖问题学院科学会议(CPDD)
- 批准号:1023087310230873
- 财政年份:2021
- 资助金额:$ 9.5万$ 9.5万
- 项目类别:
Influence of Orexin Antagonism on Motivation for Cocaine
食欲素拮抗作用对可卡因动机的影响
- 批准号:97658049765804
- 财政年份:2019
- 资助金额:$ 9.5万$ 9.5万
- 项目类别:
Influence of Orexin Antagonism on Motivation for Cocaine
食欲素拮抗作用对可卡因动机的影响
- 批准号:99195359919535
- 财政年份:2019
- 资助金额:$ 9.5万$ 9.5万
- 项目类别:
Cardiovascular, Immune and Psychosocial Benefits of Reduced Cocaine Use
减少可卡因使用对心血管、免疫和社会心理的益处
- 批准号:94698529469852
- 财政年份:2017
- 资助金额:$ 9.5万$ 9.5万
- 项目类别:
Selective Monoamine Release as a Treatment for Cocaine Use Disorders
选择性单胺释放作为可卡因使用障碍的治疗
- 批准号:87538528753852
- 财政年份:2014
- 资助金额:$ 9.5万$ 9.5万
- 项目类别:
Motivation for Cocaine and Non-Drug Reinforcers: Targeting Glutamate Homeostasis
可卡因和非药物强化剂的动机:以谷氨酸稳态为目标
- 批准号:86337248633724
- 财政年份:2014
- 资助金额:$ 9.5万$ 9.5万
- 项目类别:
A Human Laboratory Study to Investigate Buspirone for Cocaine Use Disorders
调查丁螺环酮治疗可卡因使用障碍的人体实验室研究
- 批准号:83349218334921
- 财政年份:2012
- 资助金额:$ 9.5万$ 9.5万
- 项目类别:
A Human Laboratory Study to Investigate Buspirone for Cocaine Use Disorders
调查丁螺环酮治疗可卡因使用障碍的人体实验室研究
- 批准号:85182848518284
- 财政年份:2012
- 资助金额:$ 9.5万$ 9.5万
- 项目类别:
Neuropharmacology of Tramadol: Clinical Efficacy and Abuse Potential
曲马多的神经药理学:临床疗效和滥用潜力
- 批准号:77296097729609
- 财政年份:2009
- 资助金额:$ 9.5万$ 9.5万
- 项目类别:
相似海外基金
St. Jude Children's Research Hospital - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
圣裘德儿童研究医院 - 艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:1059956310599563
- 财政年份:2022
- 资助金额:$ 9.5万$ 9.5万
- 项目类别:
This proposed R13 application will focus on Endocrinology, Diabetes and Metabolism, HIV/AIDS, Gastroenterology, Cardiology, Pulmonology, Nephrology, and Oncology subspecialty topics.
拟议的 R13 应用程序将重点关注内分泌学、糖尿病和代谢、艾滋病毒/艾滋病、胃肠病学、心脏病学、肺病学、肾病学和肿瘤学亚专业主题。
- 批准号:1032063110320631
- 财政年份:2021
- 资助金额:$ 9.5万$ 9.5万
- 项目类别:
Scientific Conferences for The College on Problems of Drug Dependence (CPDD)
药物依赖问题学院科学会议(CPDD)
- 批准号:1023087310230873
- 财政年份:2021
- 资助金额:$ 9.5万$ 9.5万
- 项目类别:
This proposed R13 application will focus on Endocrinology, Diabetes and Metabolism, HIV/AIDS, Gastroenterology, Cardiology, Pulmonology, Nephrology, and Oncology subspecialty topics.
拟议的 R13 应用程序将重点关注内分泌学、糖尿病和代谢、艾滋病毒/艾滋病、胃肠病学、心脏病学、肺病学、肾病学和肿瘤学亚专业主题。
- 批准号:1044533710445337
- 财政年份:2021
- 资助金额:$ 9.5万$ 9.5万
- 项目类别:
Advancing HIV research at Mbarara University of Science and Technology (MUST) through a research administration training program with the University of Virginia
通过与弗吉尼亚大学合作的研究管理培训项目推进姆巴拉拉科技大学 (MUST) 的艾滋病毒研究
- 批准号:97694479769447
- 财政年份:2019
- 资助金额:$ 9.5万$ 9.5万
- 项目类别: